Shree Ganesh Remedies Limited

BSE:540737 Stock Report

Market Cap: ₹8.5b

Shree Ganesh Remedies Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chandulal Kothia

Chief executive officer

₹11.1m

Total compensation

CEO salary percentage100.0%
CEO tenure29.8yrs
CEO ownership70.3%
Management average tenureno data
Board average tenure4.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Chandulal Kothia's remuneration changed compared to Shree Ganesh Remedies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹279m

Jun 30 2024n/an/a

₹280m

Mar 31 2024₹11m₹11m

₹281m

Dec 31 2023n/an/a

₹220m

Sep 30 2023n/an/a

₹215m

Jun 30 2023n/an/a

₹189m

Mar 31 2023₹10m₹10m

₹170m

Dec 31 2022n/an/a

₹150m

Sep 30 2022n/an/a

₹148m

Jun 30 2022n/an/a

₹139m

Mar 31 2022₹10m₹10m

₹134m

Dec 31 2021n/an/a

₹126m

Sep 30 2021n/an/a

₹112m

Jun 30 2021n/an/a

₹101m

Mar 31 2021₹6m₹6m

₹98m

Dec 31 2020n/an/a

₹94m

Sep 30 2020n/an/a

₹92m

Jun 30 2020n/an/a

₹99m

Mar 31 2020₹5m₹5m

₹105m

Dec 31 2019n/an/a

₹95m

Sep 30 2019n/an/a

₹86m

Jun 30 2019n/an/a

₹74m

Mar 31 2019₹3m₹3m

₹62m

Dec 31 2018n/an/a

₹56m

Sep 30 2018n/an/a

₹49m

Jun 30 2018n/an/a

₹48m

Mar 31 2018₹5m₹5m

₹47m

Compensation vs Market: Chandulal's total compensation ($USD129.36K) is above average for companies of similar size in the Indian market ($USD41.99K).

Compensation vs Earnings: Chandulal's compensation has been consistent with company performance over the past year.


CEO

Chandulal Kothia (61 yo)

29.8yrs

Tenure

₹11,110,000

Compensation

Mr. Chandulal Manubhai Kothia is Promoter, Chairman and Managing Director of Shree Ganesh Remedies Limited. Mr. Kothia has experience of more than two decades in the field of Manufacturing of pharmaceutica...


Board Members

NamePositionTenureCompensationOwnership
Chandulal Kothia
Chairman & MD29.8yrs₹11.11m70.32%
₹ 6.0b
Parth Kothia
Whole Time Director & CFO4.4yrs₹5.89m2.03%
₹ 173.6m
Gunjan Kothia
Whole Time Director4.8yrs₹8.80m5.47%
₹ 467.9m
Priyam Shah
Independent Director7.3yrs₹70.00kno data
Maulikkumar Sudani
Independent Director1.3yrs₹50.00kno data
Parulben Sahani
Independent Director1.3yrs₹40.00kno data

4.6yrs

Average Tenure

33yo

Average Age

Experienced Board: 540737's board of directors are considered experienced (4.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 02:54
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shree Ganesh Remedies Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution